Ismail Çimen

Ismail Çimen

Auto-generated profile, based on publicly available information

Ismail Çimen

Department of Biological Sciences, Middle East Technical University, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
OTOzlem Tufanli
Ozlem Tufanli
Pelin TELKOPARAN AKILLILARPelin TELKOPARAN AKILLILAR
Pelin TELKOPARAN AKILLILAR
DADiego Acosta-Alvear
Diego Acosta-Alvear
BKBegum Kocaturk
Begum Kocaturk
UOUmut Inci Onat
Umut Inci Onat
EEEbru Erbay
Ebru Erbay
Significance: Endoplasmic reticulum (ER) stress is linked to the development of complex metabolic diseases, including diabetes, obesity, and atherosclerosis. Irremediable ER stress can push the unfolded protein response (UPR) toward proinflammatory and proapoptotic signaling. The need to dissociate the adaptive UPR responses from its destructive outputs has become a major challenge for therapeutic strategies aimed at mitigating ER stress that is often observed in chronic diseases. Our findings show that inositol-requiring enzyme 1 (IRE1) plays a critical role in metaflammation and that administering IRE1-specific inhibitors to hyperlipidemic mice counteracts atherosclerosis progression.

28 September 2016 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
IÇIsmail Çimen
Ismail Çimen
BKBegüm Kocatürk
Begüm Kocatürk
SKSeda Koyuncu
Seda Koyuncu
ÖTÖzlem Tufanlı
Özlem Tufanlı
UOUmut I. Onat
Umut I. Onat
EEEbru Erbay
Ebru Erbay
A bioactive lipokine promotes metabolic resilience of organelles and limits the progression of atherosclerosis.

1 March 2019 in JACC
Verified
Journal Article
Open access
UOUmut I. Onat
Umut I. Onat
AYAsli D. Yildirim
Asli D. Yildirim
ÖTÖzlem Tufanli
Özlem Tufanli
IÇIsmail Çimen
Ismail Çimen
BKBegüm Kocatürk
Begüm Kocatürk
EEEbru Erbay
Ebru Erbay
Eukaryotic cells can respond to diverse stimuli by converging at serine-51 phosphorylation on eukaryotic initiation factor 2 alpha (eIF2α) and activate the integrated stress response (ISR). This is a key step in translational control and must be tightly regulated; however, persistent eIF2α phosphorylation is observed in mouse and human atheroma. Potent ISR inhibitors that modulate neurodegenerative disorders have been identified. Here, the authors evaluated the potential benefits of intercepting ISR in a chronic metabolic and inflammatory disease, atherosclerosis. The authors investigated ISR's role in lipid-induced inflammasome activation and atherogenesis by taking advantage of 3 different small molecules and the ATP-analog sensitive kinase allele technology to intercept ISR at multiple molecular nodes. The results show lipid-activated eIF2α signaling induces a mitochondrial protease, Lon protease 1 (LONP1), that degrades phosphatase and tensin-induced putative kinase 1 and blocks Parkin-mediated mitophagy, resulting in greater mitochondrial oxidative stress, inflammasome activation, and interleukin-1β secretion in macrophages. Furthermore, ISR inhibitors suppress hyperlipidemia-induced inflammasome activation and inflammation, and reduce atherosclerosis. These results reveal endoplasmic reticulum controls mitochondrial clearance by activating eIF2α-LONP1 signaling, contributing to an amplified oxidative stress response that triggers robust inflammasome activation and interleukin-1β secretion by dietary fats. These findings underscore the intricate exchange of information and coordination of both organelles' responses to lipids is important for metabolic health. Modulation of ISR to alleviate organelle stress can prevent inflammasome activation by dietary fats and may be a strategy to reduce lipid-induced inflammation and atherosclerosis.

31 January 2013 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
STSeda Tuncay-Cagatay
Seda Tuncay-Cagatay
ICIsmail Cimen
Ismail Cimen
BSBerna Savas
Berna Savas
SBSreeparna Banerjee
Sreeparna Banerjee

11 November 2009 in Cancer Science
Verified
Journal Article
Open access
PDF file
IÇIsmail Çimen
Ismail Çimen
STSeda Tuncay-Cagatay
Seda Tuncay-Cagatay
SBSreeparna Banerjee
Sreeparna Banerjee
Colorectal carcinoma (CRC) is often lethal when invasion and/or metastasis occur. 15‐Lipoxygenase‐1 (15‐LO‐1), a member of the inflammatory eicosanoid pathway, oxidatively metabolizes linoleic acid and its expression is repressed in CRC. In this study, we investigated the hypothesis that the lack of 15‐LO‐1 expression in CRC cells might contribute to tumorigenesis. Therefore we introduced 15‐LO‐1 into HCT‐116 and HT‐29 cells that do not have detectable levels of 15‐LO‐1. Our data indicate that expression of 15‐LO‐1 significantly decreased cell proliferation and increased apoptosis. In addition, we observed a reduction in adhesion to fibronectin, anchorage‐independent growth on soft agar, cellular motility and ability to heal a scratch wound, and migratory and invasive capacity across Matrigel. 15‐LO‐1 expression also reduced the expression of metastasis associated protein‐1, a part of the nucleosome remodeling and histone deacetylase silencing complex. We propose that 15‐LO‐1 expression in CRC might contribute to the inhibition of metastatic capacity in vitro and can be exploited for therapeutic purposes. (Cancer Sci 2009;100: 2283–2291)

28 June 2012 in The FEBS Journal
Verified
Journal Article
Open access
PDF file
EAErhan Astarci
Erhan Astarci
ASAsli Sade
Asli Sade
IÇIsmail Çimen
Ismail Çimen
BSBerna Savaş
Berna Savaş
SBSreeparna Banerjee
Sreeparna Banerjee
Intestinal epithelial differentiation entails the formation of highly specialized cells with specific absorptive, secretory, digestive and immune functions. Cell–cell and cell–microenvironment interactions appear to be crucial in determining the outcome of the differentiation process. Using the Caco‐2 cell line, which undergoes spontaneous re‐differentiation when grown past confluency, we observed a loss of VCAM‐1 (vascular cell adhesion molecule 1) mRNA expression, while ICAM‐1 (intercellular cell adhesion molecule 1) mRNA expression was seen to increase over the course of differentiation. Protein kinase Cθ (PKCθ) acted downstream of protein kinase Cα (PKCα) to inactivate inhibitor of κB (IκB) and activate nuclear factor κB (NF‐κB) in undifferentiated cells, and this pathway was inhibited in the differentiated cells. The increase in ICAM‐1 mRNA expression in the differentiated cells was due to increased promoter recruitment of C/EBPβ, which transcriptionally up‐regulated ICAM‐1 mRNA. However, protein expression of ICAM‐1 was found to decrease over the course of differentiation due to degradation in the proteasome and lysosome. Immunohistochemistry using tumor samples from colon cancer patients indicated that non‐transformed matched normal cells (well‐differentiatied) showed no ICAM‐1 expression, but the poorly differentiated tumor cells showed higher expression. Functionally, a decrease in adhesion to human umbilical vein endothelial cells was observed in the differentiated Caco‐2 cells. Thus, regulation of ICAM‐1 and VCAM‐1, although both NF‐κB target genes, appears to be different over the course of epithelial differentiation in Caco‐2 cells.